Abbott clinical biochemical second-generation total bilirubin test group
Taiwan·Risk Class 2·ABBOTT IRELAND DIAGNOSTICS DIVISION·Registered Oct 19, 2022 – Oct 19, 2027Active- Analysis ID
- 43649074541ab9815c5a3707ee4eaa8f
- Customs Code
- DHA05603586606
- Manufacturer
- ABBOTT IRELAND DIAGNOSTICS DIVISION
- Manufacturer Country
- Ireland
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
- Intended Use
- This product is used to quantify total bilirubin in human serum or plasma in adults and newborns on the ARCHITECT c System.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1110 Bilirubin (total or direct) test system
- Import Information
- QMS/QSD;; 輸入
- Registration Date
- Oct 19, 2022
- Expiry Date
- Oct 19, 2027
Access comprehensive regulatory information for Abbott clinical biochemical second-generation total bilirubin test group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 43649074541ab9815c5a3707ee4eaa8f and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.